Tasaki Y - Search Results

1

Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate.

Kotake Y, Yoshida M, Ogawa M, Tasaki Y, Hirobe M, Ohta S. Kotake Y, et al. Among authors: tasaki y. Neurosci Lett. 1996 Oct 11;217(1):69-71. doi: 10.1016/0304-3940(96)13065-2. Neurosci Lett. 1996. PMID: 8905742

2

1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.

Tasaki Y, Makino Y, Ohta S, Hirobe M. Tasaki Y, et al. J Neurochem. 1991 Dec;57(6):1940-3. doi: 10.1111/j.1471-4159.1991.tb06407.x. J Neurochem. 1991. PMID: 1940911

3

Confirmation of the enantiomers of 1-methyl-1,2,3,4-tetrahydroisoquinoline in the mouse brain and foods applying gas chromatography/mass spectrometry with negative ion chemical ionization.

Makino Y, Tasaki Y, Ohta S, Hirobe M. Makino Y, et al. Among authors: tasaki y. Biomed Environ Mass Spectrom. 1990 Jul;19(7):415-9. doi: 10.1002/bms.1200190706. Biomed Environ Mass Spectrom. 1990. PMID: 2205314

4

Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer.

Ohta S, Tachikawa O, Makino Y, Tasaki Y, Hirobe M. Ohta S, et al. Among authors: tasaki y. Life Sci. 1990;46(8):599-605. doi: 10.1016/0024-3205(90)90128-e. Life Sci. 1990. PMID: 2308469

5

A novel and neurotoxic tetrahydroisoquinoline derivative in vivo: formation of 1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline, a condensation product of amphetamines, in brains of rats under chronic ethanol treatment.

Makino Y, Ohta S, Tasaki Y, Tachikawa O, Kashiwasake M, Hirobe M. Makino Y, et al. Among authors: tasaki y. J Neurochem. 1990 Sep;55(3):963-9. doi: 10.1111/j.1471-4159.1990.tb04585.x. J Neurochem. 1990. PMID: 2384762

6

1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF.

Kotake Y, Tasaki Y, Makino Y, Ohta S, Hirobe M. Kotake Y, et al. Among authors: tasaki y. J Neurochem. 1995 Dec;65(6):2633-8. doi: 10.1046/j.1471-4159.1995.65062633.x. J Neurochem. 1995. PMID: 7595560

7

Biosynthesis of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), a possible antiparkinsonism agent.

Tasaki Y, Makino Y, Ohta S, Hirobe M. Tasaki Y, et al. Adv Neurol. 1993;60:231-3. Adv Neurol. 1993. PMID: 8420139 No abstract available.

8

Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice: in vivo and in vitro studies.

Kotake Y, Tasaki Y, Hirobe M, Ohta S. Kotake Y, et al. Among authors: tasaki y. Brain Res. 1998 Mar 23;787(2):341-3. doi: 10.1016/s0006-8993(97)01560-6. Brain Res. 1998. PMID: 9518683

9

Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins.

Kotake Y, Taguchi R, Okuda K, Sekiya Y, Tasaki Y, Hirobe M, Ohta S. Kotake Y, et al. Among authors: tasaki y. Brain Res. 2005 Feb 8;1033(2):143-50. doi: 10.1016/j.brainres.2004.11.019. Brain Res. 2005. PMID: 15694918

10

Differential effects of [3H]nemonapride and [3H]spiperone binding on human dopamine D4 receptors.

Hidaka K, Matsumoto M, Tada S, Tasaki Y, Yamaguchi T. Hidaka K, et al. Among authors: tasaki y. Neurosci Lett. 1995 Feb 17;186(2-3):145-8. doi: 10.1016/0304-3940(95)11306-h. Neurosci Lett. 1995. PMID: 7777184

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters